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INTRODUCTION 
 Local anesthesia plays the most important role for pain control in 
dentistry. The first substance used for pain control in dentistry was cocaine, as 
far back as in 1884. In 1903, Abel discovered Adrenaline .Broun suggested 
using adrenaline as a “chemical tourniquet”as it prolongs the duration of local 
anesthetic agent.  In 1904 Einhorn synthesized procaine, an ester anesthesia. In 
the 1940’s a new group of local anesthetic compounds, the amides, were 
introduced. A Swedish chemist Nils Lofgren, synthesized lignocaine, an 
Amide Local anesthetic agent in 1943 which revolutionized pain control in 
dentistry worldwide, as it was both more potent and less allergenic than 
procaine. In the succeeding years, other amide local anaesthetics (prilocaine in 
1953 by Lofgren and Tegner, bupivacaine and mepivacaine in 1957 by A. F. 
Ekenstam, etidocaine in 1971 by Takman) were introduced. These local 
anesthetic agents provide pulpal anesthesia for periods lasting from 20 minutes 
(mepivacaine) to as long as three hours (bupivacaine and etidocaine with 
adrenaline). In addition, these popular drugs proved to be more rapid-acting 
than the older ester-type drugs and, at least from the perspective of 
allergenicity, safer. 
 In 1969, Rusching et al. prepared a new drug, Articaine in Germany, 
where it entered clinical
 
use in 1976. It was first named Carticaine, but its 
generic name was changed to Articaine in 1984. In April 2000, the U.S. Food 
and Drug Administration
 
granted approval for the sale of 4% Articaine with 
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1:100,000
 
adrenaline in the United States under the name of Septocaine
 
(Septodont).
  
4% Articaine with 1:100,000 adrenaline is a safe local
 
anesthetic 
for use in clinical dentistry in both adults and
 
children
11,14,30
. Articaine 
hydrochloride is an amide local anesthetic, 4-methyl-3[2-(propyl-amino)
 
propionamido]-2 thiophenecarboxylic acid, methyl ester hydrochloride. 
 Articaine differs from other amide local anesthetics in that it
 
contains a 
thiophene group, which increases its liposolubility,
 
and is the only widely used 
amide local anesthetic that also
 
contains an ester group. The ester group 
enables articaine to
 
undergo biotransformation in the plasma (hydrolysis by 
plasma
 
esterase) as well as in the liver (by hepatic microsomal enzymes).
 
The 
primary metabolite, articainic acid, is inactive.
 
Articaine
 
and its metabolites 
are eliminated via the kidneys. Approximately
 
5 percent to 10 percent of 
articaine is excreted unchanged 
29,38,51 
. 
                 Action of Articaine is similar to other local anesthetics in reversibly 
blocking nerve conduction 
1,7,6,8,12,26,27,29,30,36,37,41,43,44,46,52
.
 
Adrenaline is 
included in the clinical formulation both to
 
retard absorption of articaine, 
thereby prolonging the duration
 
of clinically adequate anesthesia, and to 
minimize systemic
 
absorption of the active drug. Though Articaine is available 
as 4% with 1:100,000 or 1:200,000 adrenaline, according to Carlos.F.Santos et 
al’s5  study conducted both the solutions had equal latency, duration of post- 
operative analgesia ,duration of anesthetic actions on soft tissues , intra-
operative bleeding and hemodynamic parameters. 
Introduction 
3 
 
 The onset of anesthesia 4% Articaine 1:100,000 adrenaline is 1.5 to 1.8 
minutes for
 
maxillary infiltration and 1.4 to 3.6 minutes for inferior alveolar
 
nerve block. The duration of soft-tissue anesthesia for 4% articaine 1:200,000 
adrenaline is 2.25hrs for maxillary infiltration and 4hrs
 
for nerve block
30
. The 
anesthetic activity of articaine/adrenaline combinations has been demonstrated 
to be comparable to that
 
of other anesthetic combinations, including lidocaine/ 
epinephrine, mepivacaine / levonordefrin and prilocaine /                          
epinephrine
 1,7,6,8,12,26,27,29,30,36,37,41,43,44,46,52
. 
 Inferior alveolar nerve block is the most commonly used anesthetic 
technique for various dental procedures in the mandibular teeth. This 
technique is a difficult technique for beginners and has the highest failure rate 
owing to several factors, including, difficulty in identification of landmarks, 
and complications like trismus, heamatoma formation, facial nerve palsy etc. 
Supplementary injections can be useful in overcoming such failure
18,19,26
. 
Rosenberg and colleagues
44
 showed articaine and lignocaine to have a similar 
efficacy for pain reduction when given as a supplemental buccal infiltration 
for inadequate pulpal anesthesia during endodontic procedures. Additionally, 
the combination of a buccal and lingual infiltration of lignocaine has been 
shown to be more effective than buccal alone in obtaining pulpal anesthesia of 
lower anterior teeth 
38
 .  
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 However, buccal and buccal plus lingual infiltrations of articaine with 
epinephrine did not differ in their efficacy in obtaining pulpal anesthesia for 
mandibular permanent first molars 
20
.            
 The recent work done by Robertson and collegues 
13 
showed that 
Buccal infiltration of 4% Articaine with 1:100,000 adrenaline is more 
effective than a similar injection of 2% Lidocaine with 1:100,000 adrenaline  
in obtaining pulp anesthesia in mandibular molars of healthy volunteers .The 
success of mandibular infiltration with 4% articaine and adrenaline for first 
molar anesthesia is comparable to that of an inferior alveolar nerve block with 
2% lignocaine and epinephrine when similar outcome measures are used. A 
recent blinded crossover study by Il – Young Jung21 indirectly compared the 
two techniques, with statistically comparable success of around 50% for 
articaine infiltration and lignocaine inferior alveolar nerve blocks for 
mandibular first molar anesthesia.  Anesthetic efficacy of 4% articaine with1: 
100,000 adrenaline infiltrations for first molar pulp anesthesia was similar to 
that of an Inferior alveolar nerve block using 2% Lignocaine with 1: 80,000 
adrenaline over  30minutes. The discomfort of buccal infiltration with 
articaine was dependent on the volume injected and similar to that of an 
Inferior alveolar nerve block.  
          Mandible is made of thick cortical bone.  Due to the increased thickness 
of the buccal bone when compared to maxillary bone which is thin porous  and 
cancellous, local infiltration of 2% Lignocaine with 1:80,000 adrenaline 
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cannot penetrate the bone efficiently and produce pulpal anesthesia when local 
infiltration injection given. Even for a single molar tooth extraction inferior 
alveolar nerve block technique supplemented with buccal nerve infiltration has 
been the choice to anesthetize the tooth before extraction. Studies have shown 
that 4% Articaine with 1:100,000 has excellent buccal bone penetrating 
property and can anesthetize the pulp satisfactorily during root canal therapy. 
 This study has been designed to evaluate and compare the anesthetic 
efficiency of 4% Articaine with 1:100,000 adrenaline using local buccal and 
lingual infiltration injection technique versus 2% Lignocaine with 1:80,000 
adrenaline using conventional inferior alveolar nerve block technique in adult 
patients undergoing mandibular erupted first and second molars extraction. 
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PHARMACOLOGY 
 Lignocaine (2-Diethylamino 2’,6 –acetoxylidide hydrochloride) 
ia the most commonly used amide local anesthetic. Lignocaine is 
metabolized in the liver into monoethyiglyceine and xylidide by 
microsomal fixed function oxidases. Xylidide is a local anesthetic and 
potentially toxic. Lignocaine is excreted via kidneys, less than 10% 
unchanged, more than 80% various metabolites. It’s anesthetic half –life 
is about 90 minutes (1.6 hrs). 
 The manufacturer’s maximum recommended dose of lidocaine 
with epinephrine is 6.6mg /kg and without adrenaline is 4.4mg/kg.  
 
 
              
 
 Articaine (4-methyl-3-[2-(propylamino) - propionamido]-2-
thiophene-carboxylic acid, methyl ester hydrochloride) is a unique 
amide LA in that it contains a thiophene, instead of a benzene ring. The 
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thiophene ring allows greater lipid solubility and potency as a greater 
portion of an administered dose can enter neurons. It is the only amide 
anaesthetic containing an ester group, allowing hydrolysation in 
unspecific blood esterases. Articaine’s amide linkage undergoes bio-
transformation in the liver, a relatively slow process, however articaine 
is additionally inactivated by serum esterases, a fast process 
commencing immediately after injection. 
 About 90% of articaine metabolises quickly via hydrolysis in the 
blood into its inactive metabolite articainic acid, which is excreted by 
the kidney in the form articainic acid glucuronide. The elimination 
serum half-life of articaine is 20 minutes and of articainic acid is 64 
minutes. Equal analgesic efficacy and a lower systemic toxicity (a wide 
therapeutic range) allows articaine use in a concentration higher than 
other amide LAs. 
 It is believed that local saturation of serum esterases, causing 
slower and prolonged metabolism, may contribute to the advantageous 
relationship between persistence of the local anesthetic effect and low 
systemic toxicity. The maximum recommended dosage for articaine 
with epinephrine is 7mg /kg. 
 The increased duration of the local anaesthetic effect may also 
be related to the high degree of protein binding, where the increased 
tendency for articaine to attach securely to the protein receptor site may 
provide a longer duration of clinical activity.  There is no correlation 
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between the serum concentration and local anaesthetic effect of 
articaine
26
.  
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AIMS AND OBJECTIVES 
 To assess the anesthetic efficacy of 4% Articaine with 1:1,00,000 
adrenaline given as buccal and lingual infiltration in adult patients undergoing 
erupted mandibular first and second molar extraction. 
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REVIEW OF LITERATURE 
 Dudkiewicz A (1987)
 11
 .,  Fifty children with a mean age of 7 years, 
ranging from 4-10 years, were enrolled in a study comprising the application 
of mandibular infiltration using articaine hydrochloride for conventional 
operative dentistry of posterior primary mandibular teeth. Articaine 
hydrochloride produced an appropriate deep anesthesia in all treated patients. 
The authors have recommended that mandibular infiltration using articaine is 
effective and safe and has a potential of being the technique of choice. 
 Muller .W.P et al (1991)
 34 
., conducted a study to know the, exact 
blood concentrations resulting from the use of the local anesthetics .They 
stated that due to the high vascularity a rapid increase in serum local 
anesthetic levels is to be expected. Due to analytical problems, the literature 
provides controversial statements about the pharmacokinetics of articaine 
which is generally used for this block. The given half-life periods following 
intramuscular application range from 39 min 8 to 31 h 6. For this reason, 
mandibular nerve blocks with 2 ml 4% articaine with 1:200,000 epinephrine 
were carried out in 10 awake patients and 10 patients during intubation 
anesthesia. The blood samples from peripheral veins showed an average 
maximum concentration of 2.1 1.3 mg/l after 12.5 2.5 min. After 8 h the value 
had fallen below the minimum detection limit of 0.05 mg/l. In the present 
study, a half-life of approximately 20 min was determined for articaine after 
conduction anesthesia. This local anesthetic holds an exceptional position 
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because as an amide-type local anesthetic it contains an additional ester group 
that is hydrolytically metabolized in the blood. The concentration of the 
resulting metabolite reached a maximum value of 2.6 1.6 mg/l after 40 to 50 
min. they concluded that compared to other amide-type local anesthetics, 
whose terminal plasma half-life varies between 1 and 3.6 h 5, the value of 20 
min found for articaine is very low. This is in part due to its structure, as the 
ester group is rapidly metabolized by plasma esterases. Because of its rapid 
breakdown articaine is very suitable for use in oral surgery. The HPLC 
method represents an uncomplicated analytical technique for the determination 
of local anesthetics levels in blood and other body fluids. 
 Kimmo Vahatalo et al (1993)
 27
., conducted a study to compare the 
anesthetic properties of articaine hydrochloride with 1:2,00,000 epinephrine 
and lidocaine with 1:80,000 epinephrine for maxillary infiltration anesthesia. 
They found no statistically significant differences between the articaine and 
lidocaine solutions with respect to onset and duration of action. 
 Celia Mc Lean et al (1993)
 7
 ., conducted a  study  to measure the 
degree of anesthesia obtained with 4% prilocaine and 3% mepivacaine 
compared with 2% lidocaine (1:100,000 epinephrine) for inferior alveolar 
nerve block. Using a repeated measures design, 30 subjects randomly received 
an inferior alveolar injection using masked cartridges of each solution at three 
successive appointments. The first molar, first premolar, lateral incisor, and 
contralateral canine (control) were blindly tested with an Analytic Technology 
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pulp tester at 3-min cycles for 50 min. Anesthetic success was defined as no 
subject response to the maximum output of the pulp tester (80 reading) within 
16 min and maintenance of this reading for 50 min. Although subjects felt 
numb subjectively, anesthetic success as defined here occurred in 43 to 63% 
of the molars, in 53 to 67% of the premolars, and in 30 to 37% of the lateral 
incisors. No statistically significant differences in onset, success, or failure 
were found among the solutions. They conclude that the three preparations are 
equivalent for an inferior alveolar nerve block of 50-min duration. 
    Hass et al (1995)
 18 
., A retrospective study of paresthesia following the 
injection of local anaesthetic in dentistry from 1973 to 1993 has been done. 
Only those cases in which surgery was not conducted were considered in this 
study. From 1973 to 1993, there were 143 reports of paresthesia not associated 
with surgery. No significant differences were found with respect to patient 
age, patient gender, or needle gauge. All reports involved anaesthesia of the 
mandibular arch, with the tongue most frequently reported to be symptomatic, 
followed by the lip. Pain was reported in 22% of the cases. Paresthesia was 
reported most often following the injection of articaine and prilocaine. In 1993 
alone, there were 14 reports of paresthesia not associated with surgery. This 
can be projected to an incidence of 1:785000 injections. Articaine was 
administered in 10 of these cases and prilocaine in the other four. The 
observed frequencies of paresthesia following the administration of articaine 
or prilocaine were significantly greater than the expected frequencies for these 
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agents, based on the distribution of local anaesthetics use in Ontario in 1993. 
Authors suggested that local anaesthetic formulation 20s might have the 
potential for mild neurotoxicity.  
 Jakobs W Ladwig B (1995)
 22 
., have studied the pharmacokinetics of 
articaine in children. The maximum values were distinctly lower with the 2% 
articaine solution. The plasma clearance was distinctly earlier than in 
comparable investigations in adults. They have recommended that there is no 
need to fix a lower mg/kg articaine dose limit for children because of age-
related differences in the pharmacokinetics and the use of 2% articaine in 
pediatric dentistry is particularly advantageous because of the lower C max 
and the shorter half-life.  
 Childers M et al (1996)
 8
 ., conducted a study whose objective was  to 
compare the anesthetic efﬁcacy of the intraligamentary injection of 4% 
articaine with 1:100,000 epinephrine and of 2% lidocaine with 1:100,000 
epinephrine, administered with computer-controlled local anesthetic delivery 
system, in mandibular posterior teeth. The study design was a crossover 
design, intraligamentary injections of 1.4 mL of 4% articaine with 1:100,000 
epinephrine and of1.4 mL of 2% lidocaine with 1:100,000 epinephrine who 
were randomly a dministered with a computer-controlled local anesthetic 
delivery system, in a double-blind manner on the mesial and distal aspects of a 
mandibular ﬁrst molar, at 2 separate appointments to 51 subjects. A pulp tester 
was used to test for anesthesia, in 2-minute cycles for 60 minutes, of the 
mandibular ﬁrst and second molars and second premolar. Anesthesia was 
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considered successful when 2 consecutive 80 readings (highest output) were 
obtained within 20 minutes. The results showed successful pulpal anesthesia 
was obtained 86% of the time for the ﬁrst molar using the articaine solution 
and 74% of the time using the lidocaine solution. There were no signiﬁcant 
differences (P < .05) between the articaine and lidocaine solutions 
 The mean onset times of pulpal anesthesia for the ﬁrst molar were 1.3 
minutes with articaine solution and 2.2 minutes with lidocaine solution. 
Duration of pulpal anesthesia for the ﬁrst molar was 34 minutes for the 
articaine solution and 31 minutes for the lidocaine solution. They concluded 
that the efﬁcacy of 4% articaine with 1:100,000 epinephrine was similar to the 
efﬁcacy of 2% lidocaine with 1:100,000 epinephrine for intraligamentary 
injections.       
                Bircher.A.J et al (1996)
 4
 ., A case of 43 year old woman who 
suffered from recurrent localized swellings and an eczematous dermatitis 
starting one day after an injection of lignocaine has been reported. The 
investigators confirmed hypersensitivity with intradermal patch and 
lymphocyte transformation tests, which revealed sensitization to lignocaine 
and cross-reactivity to the other aminoacylamide local anesthetics 
bupivacaine, mepivacaine and prilocaine, but not to articaine. Contact allergy 
to the ester local anesthetics benzocaine, procaine and tetracaine, the quinoline 
or aminoacylamide cinchocaine, and the preservatives methylparaben and 
metabisulfite, was excluded. They also did a subcutaneous challenge test with 
articaine, which was well tolerated. 
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               Oertal et al (1997)
 39 
., studied the pharmacokinetics of  Articaine 
and concluded that it is the most widely used local anaesthetic agent in 
dentistry in a number of European countries. The amide structure of articaine 
is similar to that of other local anaesthetics, but it contains an additional ester 
group which is quickly hydrolysed by esterases. High performance liquid 
chromatography has been used to determine the concentrations of articaine 
and its metabolite articainic acid in serum. Rapid sample preparation is critical 
in the accurate determination of articaine serum concentrations, since blood 
and serum are the sites of metabolism. The time to maximum drug 
concentrations of articaine occurs about 10 to 15 minutes after submucosal 
injection of articaine 4% 80mg, irrespective of epinephrine (adrenaline). The 
mean maximum plasma drug concentration is about 400 μg/L for articaine 
with epinephrine 1:200,000 and 580 μg/L for articaine without epinephrine. 
The elimination half-time of articaine is about 20 minutes. The rapid 
breakdown of articaine to the inactive metabolite articainic acid is related to a 
very low systemic toxicity and consequently to the possibility of repeated 
injections. Equal analgesic efficacy along with lower systemic toxicity (i.e. a 
wide therapeutic range) permits the use of articaine in higher concentrations 
than other amide-type local anaesthetics. Complete anaesthesia can be 
observed in nearly 90% of all cases, using articaine 4% 60 to 80mg with 
epinephrine 1: 200 000. Articaine is better able to diffuse through soft tissue 
and bone than other local anaesthetics. The concentration of articaine in the 
alveolus of a tooth in the upper jaw after extraction was about 100 times 
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higher than that in systemic circulation. The plasma protein binding rate of 
articaine and articainic acid is 70%. It has been concluded that an 
unintentional intravascular injection of articaine 80mg does not cause toxic 
effects in healthy individuals. 
 Simon et al (1997)
 46 
, A study was done to know the effectiveness of 
three local anesthetic agents for intravenous regional anesthesia in the upper 
limb. Side effects and plasma concentrations of the drugs in the doses 
administered for IVRA were also studied. The time of onset for sensory block 
was significantly shorter (2.5 minutes) in the articaine group than in the 
lignocaine group (11.1 minutes) or the prilocaine group (10.9 minutes). 
Development of motor block was equal in all three groups. Maximum 
concentrations of articaine, lignocaine, and prilocaine were, 1.85, 8.5, and 4.4 
micrograms/ml, respectively. It was found that articaine had the fastest onset 
of sensory block and the lowest peak plasma concentration of the three local 
anesthetics when used for intravenous regional anesthesia. 
 Oertal et al (1999)
 40 
., Study was done to evaluate the effect of age on 
pharmacokinetics of the local anesthetic agent articaine. Submucosal 
infiltration anesthesia from two different dosages of 4% articaine without 
epinephrine was compared in healthy elderly and young volunteers. High 
performance liquid chromatography has been used to determine concentrations 
of articaine in serum. Basic pharmacokinetic parameters were calculated 
according to standard procedures. The area under the serum concentration 
time curve and maximum drug concentration (Cmax) values did not differ 
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significantly with age; however, both parameters tended to be higher in elderly 
volunteers. No changes in terminal half-life and time to reach maximum serum 
concentration (tmax) were observed and concluded that the metabolism of 
articaine is age independent. No change of dosage of articaine in elderly 
patients should be necessary.  
 Stanley F. Malamed et al (2000)
 29
 ., In a study three identical 
randomized blind multi center trials subjects between 4-80 years of age 
received 4% articaine with 1:100000 epinephrine or 2% lignocaine with 
1:100,000 epinephrine for simple or complex procedures. The authors found 
no statistical difference between the two treatment groups with respect to 
subject or investigator pain ratings using the VAS and concluded that 4% 
articaine was well tolerated in 882 subjects. Articaine provided clinically 
effective pain relief during most dental procedures and had a time of onset and 
duration of anesthesia appropriate for clinical use. 
 Schertzer et al ( 2000) 
44 .,
 In his letter quires substantial reasons to 
utilize 4% articaine instead of usual 2% lignocaine and the maximum dose of 
articaine able to safely inject during a single dental appointment.  Malamed 
has replied that clinical observations indicate that articaine possesses two 
features that doctors find important; faster onset of action and “You don’t miss 
as often” and clinical significance in minimizing the risk of overdose as 
elimination half life of most amide local anesthetics is approximately 90 
minutes where as that of articaine is 27 minutes.  
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 Giovana Radomille Tofoli et al (2000)
 17
., compared 20 healthy 
volunteers and evaluated the anesthetic efficacy of 4% articaine in association 
with 2 different concentrations of epinephrine, 1;2,00,000 and 1:1,00,000 in 
inferior alveolar nerve block. They concluded that both solutions presented the 
same clinical effectiveness in blocking the inferior alveolar nerve. 
 Carrera I et al (2000)
 6
., conducted a study to observe the 
hemodynamic changes during surgical extraction of lower third molars 
induced by three local anesthetics solutions associated with different 
vasoconstrictors. Three groups were established according to the anesthetic 
solution and associated vasoconstrictor administered (4% articaine + 
epinephrine 1:200,000, 3% mepivaciane without vasoconstrictor, and 3% 
prilocaine + felypressin 1:1,850,000). Heart rate, systolic and diastolic 
pressure, and oxygen saturation were recorded at different times before, during 
and at the end of surgery, along with the type and amount of anesthetic 
solution administered. The study variables were found to be more stable with 
articaine + epinephrine 1:200,000, although the three studied solutions caused 
no significant hemodynamic changes with respect to the basal values when 
administered in healthy patients subjected to surgical removal of a lower third 
molar.  
 Staneley F. Malamed et al (2001)
 30
 ., Conducted a study to compare 
the safety and efficacy of articaine (4 percent with epinephrine 1:100,000) to 
lignocaine. A total of 1,325 subjects participated in these studies, 882 of them 
received articaine 4 percent with epinephrine 1:100000. The overall incidence 
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of adverse events in the combined studies was 22 percent for the articaine 
group and 20 percent for the lignocaine group. The most frequently reported 
adverse events in the articaine group, excluding post procedural dental pain, 
were headache (4 percent), facial edema, infection, gingivitis and paresthesia 
(1 percent each). 
 J.G. Meechan (2002)
 24
., described supplementary techniques 
available to provide pulpal anesthesia   and  concluded that when conventional 
techniques fail, supplementary techniques increase the  incidence of pulpal 
anesthesia when used in combination with standard techniques.
 
 Van Eden S P Patel M F et al (2002)
 50 
.,  Articaine is the most 
widely used local anesthetic in a number of European countries, and is been in 
use in UK since 1998. It is said to have a number of advantages, namely, low 
systemic toxicity due to rapid breakdown to an inactive metabolite articainic 
acid; rapid onset of surgical analgesia (2.2min) faster elimination time than 
lignocaine; Better diffusion through soft tissue and bone than other local 
anesthetics; and lack of toxic effects in healthy individuals following 
unintentional intra vascular injection. 
 Zolkowska D et al (2000)
 53
 ., compared the interaction between local 
anesthetics and centrally acting antihypertensive drugs and concluded that 
articaine is the most safe local anesthetic and can be used in epileptic patients 
.Co- administration of local anesthetics with centrally acting antihypertensive 
drugs did not influence seizures activity in mice. 
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 Dogan N et al (2003)
 12
., an animal study forty rats were used to 
know the wound response with articaine. The rats were randomly separated 
into 4 groups. Three groups were given 2% lignocaine, 4% articaine, or 
injectable saline and the fourth was a control group. Skin specimens 
underwent the breaking strength test and histologic examination at one week 
after the surgical procedure. The skin specimens of the rats were subjected to 
a pulling force of 10mm/min across the incision line. The strength value at 
the moment of breaking in the tissue was expressed in Newton. Histologic 
examination was performed as well, and wound healing was graded. Both 
the histologic grade and BST values in the lignocaine and articaine groups 
were significantly lower than those of the control and saline groups. 
Similarly, the histologic and BST values of the articaine and lignocaine 
groups were statistically significant. Some necrotic regions were observed at 
the incision region in two samples from the articaine group. Authors have 
concluded that articaine is as safe a local anesthetic agent as lignocaine from 
the standpoint of wound response. 
 Wynn RL et al (2003)
 52
., A review of reports of incidence of 
paresthesia and recent reports of increased incidence of paresthesia with use 
of articaine has been done. Taking account of total number of cartridges 
used during 1993 and 1994 projected an incidence of 2.98 paresthesia cases 
per million injections of prilocaine and 2.05 cases per million injections of 
articaine. One of the authors is an oral surgeon, believes articaine is well 
tolerated and effective but has not found any clinical advantages, and how 
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ever suggests that articaine is safer when a procedure requires multiple 
injections. They have commented that articaine has slightly greater or equal 
incidence compared to other local anesthetics. 
 Nusstein J, Berlin J et al (2004)
 36
., A comparison of pain of 
injection, heart rate increase, and post injection pain of the intraligamentary 
injection of 4% articaine with 1:100,000 epinephrine and 2% lignocaine with 
1:100,000 epinephrine administered with a computer-controlled local 
anesthetic delivery system has been done. Results demonstrated the 
incidence of moderate pain was 14%-27% with needle insertion, with 0%-
4% reporting severe pain. For solution deposition, moderate pain was 
reported 8%-18% of the time, with no reports of severe pain. There were no 
significant differences between the articaine and lignocaine solutions. 
Regarding heart rate changes, neither anesthetic solution resulted in a 
significant increase in heart rate over baseline readings.  
 Claffey, Elizabeth et al (2004)
 9
 ., The purpose of this prospective, 
randomized, double-blind study was to compare the anesthetic efficacy of 
4% articaine with 1:100,000 epinephrine to 2% lidocaine with 1:100,000 
epinephrine for inferior alveolar nerve blocks in patients experiencing 
irreversible pulpitis in mandibular posterior teeth. Seventy-two emergency 
patients diagnosed with irreversible pulpitis of a mandibular posterior 
toothrandomly received, in a double-blind manner, 2.2ml of 4% articaine 
with 1:100,000 epinephrine or 2.2ml of 2% lidocaine with 1:100,000 
epinephrine using a conventional inferior alveolar nerve block. Endodontic 
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access was begun 15 min after solution deposition, and all patients were 
required to have profound lip numbness. Success was defined as none or 
mild pain (Visual Analogue Scale recordings) on endodontic access or 
initial instrumentation. The success rate for the inferior alveolar nerve 
block using articaine was 24% and for the lidocaine solution success was 
23%. There was no significant difference (p < 0.89) between the articaine 
and lidocaine solutions. Neither solution resulted in an acceptable rate of 
anesthetic success in patients with irreversible pulpitis.  
  Oliveira P.C et al (2004)
41
.,  The purpose of this study was to 
evaluate the onset of action of pulpal and soft tissue anaesthesia, and pain 
experience after buccal and palatal infiltrative injections with 4% articaine 
with 1:100,000 adrenaline, and 2% lignocaine with 1:100,000 adrenaline. A 
double blind cross-over study was conducted with 20 healthy adult subjects 
who, in two appointments at least two weeks apart, randomly received an 
infiltration anaesthesia with the solutions in the buccal and palatal regions 
of the upper right canine. The tooth was tested with a pulp tester before (to 
establish its baseline response), and after the injection, until return to the 
base threshold level. The pain experience caused by palatal injection was 
verified by the visual analogue scale (VAS). Data were analysed using 
Wilcoxons test (alpha = 0.05).There were no significant statistical 
differences between the solutions with respect to VAS (p = 0.45), onset of 
action (p = 0.80) and pulpal (p = 0.08) and soft tissue (p = 0.18) anaesthesia 
duration, although pulpal anaesthesia may have reached statistical 
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significance if a higher number of volunteers had been used. Under the 
conditions of this study it can be concluded that both anaesthetic solutions 
showed similar pain experience. 
 Costa CG et al (2005)
 10
 ., Twenty healthy patients who received 1.8 
ml of one of the three local anesthetics during operative dental procedures 
were examined. Onset and duration were determined by electric pulp tester. 
Onset time was 2.8 1.6,1.4 minutes and duration were 39.2, 56.7and 66.3 
minutes respectively for 2% lignocaine with 1:100000 epinephrine 4% 
articaine with 1:200000 epinephrine and 4% articaine with 1:100000 
epinephrine. They concluded that articaine produced shorter onset and 
longer duration of action of pulpal anesthesia by maxillary infiltration than 
lignocaine.  
 Vree and Gielen (2005)
 51
., have stated in their study that the 
concentration of articaine in the alveolus of a tooth in the upper jaw after 
extraction was about 100 times higher than that in systemic circulation 
articaine is metabolized via hydrolysis into articainic acid, 75% of which is 
excreted as the acid; 25% of the acid is excreted, in the glucuronidated form, 
by the kidney the half-lives of elimination of articaine are 0.6 and 2.5 hours, 
whereas the apparent half-life of the metabolite articainic acid is 2.5 hours. 
Intrinsic half-lives of articainic acid are: t1⁄2 a 12 minutes, and t1⁄2 b 64 
minutes (1 hour). The renal excretion of articainic acid and glucuronide is 
100%, with 25%glucuronidation by the kidney.  
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 Nusstein J (2005)
 37
., A prospective, randomized, double blind study 
to compare the degree of pulpal anesthesia obtained with 4% articaine with 
1:100000 epinephrine and 2% lignocaine with 1:100000 epinephrine in 
inferior alveolar nerve blocks has been done. Using a crossover design, 
inferior alveolar nerve blocks were randomly administered, in a double-blind 
manner, using 4% articaine with 1:100000 epinephrine and 2% lignocaine 
with 1:100000 epinephrine, at two separate appointments, to 57 subjects. 
Using the articaine solution, successful pulpal anesthesia ranged from 4 to 
54% from the central incisor to the second molar. Using the lignocaine 
solution, successful pulpal anesthesia ranged from 2 to 48%. The authors have 
concluded that 4% articaine with 1:100000 epinephrine was similar to 2% 
lignocaine with 1:100000 epinephrine in inferior alveolar nerve block. 
 El-Qutob D (2005)
 15
 ., reported the case of a 51-year-old woman who 
had an immediate skin reaction after subcutaneous administration of a local 
anesthetic composed of articaine and epinephrine before a dental procedure. 
The patient subsequently underwent further dental procedures without local 
anesthetic. Skin prick tests performed with commercial local anesthetics 
(lignocaine, mepivacaine, bupivacaine and articaine) turned negative except 
for articaine.  
 Hillerup S (2005)
 19 
., Fifty two patients were examined who fifty-four 
injection injuries had caused by mandibular block analgesia affecting the 
lingual nerve (42) and/or the inferior alveolar nerve (12). The perception of 
feather light touch, pinprick, sharp/dull discrimination, warm, cold, point 
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location, brush stroke direction, 2-point discrimination and pain perception 
were assessed. Gustation was tested for recognition of sweet, salt, sour and 
bitter. They found that mandibular block analgesia causes lingual nerve injury 
more frequently than inferior alveolar nerve injury and observed all grades of 
loss of neurosensory and gustatory functions were found, and a range of 
persisting neurogenic malfunctions was reported. Subjective complaints and 
neurosensory function tests indicate that lingual nerve lesions are more 
incapacitating than inferior alveolar nerve lesions. Fifty-four percent of the 
nerve injuries were associated with Articaine 4%. They commented that unlike 
most mechanical injuries after surgery, injection injuries were not followed by 
a course of spontaneous improvement of neurosensory and/or gustatory 
function indicating neurotoxicity as a central etiological factor. 
 Feck AS et al (2005)
 16 
., Local anesthetic failures in dental patients 
can have many causes, including anatomical variations, technique and 
anxiety/fear. By understanding the mechanisms responsible for failed local 
anesthesia, patients can be treated more comfortably. Oral sedation dentistry is 
highlighted as a way to reduce anxiety/fear and the patient's perception of 
pain. Profound anesthesia can be accomplished more easily in relaxed patients 
with diminished or eliminated anxiety/fear. 
 Philip Mikesell et al (2005)
 43
 ., conducted a study to compare degree 
of pulpal anesthesia obtained with 4% articaine with 1:1,00,000 epinephrine 
and 2% lidocaine with 1:1,00,000 epinephrine in inferior alveolar nerve block.  
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 They concluded that both solutions were similar in obtaining the pulpal 
anesthesia.  
 D.Ram et al ( 2006)
 14
 .,Fifty children with a mean age of 7 years, 
ranging from 4-10 years, were   enrolled in a study comprising the application 
of mandibular infiltration using articaine hydrochloride for conventional 
operative dentistry of posterior primary mandibular teeth. Articaine 
hydrochloride produced an appropriate deep anesthesia in all treated patients.  
 The authors have recommended that mandibular infiltration using 
articaine is effective and safe and has a potential of being the technique of 
choice.  
 Jason Bigby et al (2006)
 23
 ., conducted a study to determine the 
anesthetic efficacy and heart rate effect of 4% articaine with 1:1,00,000 
epinephrine for supplemental intraosseous injection in mandibular posterior 
teeth diagnosed with irreversible pulpitis. They concluded that when inferior 
alveolar nerve block fails to provide profound pulpal anesthesia, the 
intraosseous injection of 4% articaine with 1:1, 00,000 epinephrine would be 
successful 86% of times in achieving pulpal anesthesia in mandibular posterior 
teeth of patients presenting with irreversible pulpitis. 
 Mohammad Dib Kanna et al (2006)
 33
  .,  conducted a randomized, 
controlled trial of 31 healthy volunteers compared 4% articaine with 
1:100,000 epinephrine buccal infiltration to buccal plus lingual infiltration of 
the same dose of drug in achieving pulpal anesthesia of mandibular first molar 
teeth. Data were compared with efficacy of an inferior alveolar nerve block 
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using 2% lidocaine 1:80,000 epinephrine in a cohort of 27 of the volunteers. 
Anesthesia was determined using electronic pulp testing. Buccal and buccal 
plus lingual infiltrations of articaine with epinephrine did not differ in efficacy 
in obtaining pulpal anesthesia for mandibular permanent first molars                      
(p = 0.17). Efficacy of 4% articaine with epinephrine infiltrations for first 
molar pulp anesthesia was similar to that of an IANB using lidocaine with 
epinephrine over a 30-minute study period (96 and 80 episodes of no response 
to maximal stimulation respectively, p = 0.097). Subjective tooth numbness 
was more common after IANB than buccal infiltration (p = 0.005). The 
concluded that discomfort of buccal infiltration with articaine was volume 
dependent (p = 0.017) and similar to that of an IANB.      
 Sollecito et al (2006)
 47
., The authors conducted two double-blinded, 
randomized, multicenter clinical trials to determine the efficacy and clinical 
anesthetic characteristics of 4 percent articaine hydrochloride (HCl) with 
1:200,000 epinephrine (A200) as compared with those of 4 percent articaine 
HCl with 1:100,000 epinephrine (A100) and 4 percent articaine HCl without 
epinephrine and concluded that inclusion of epinephrine in 4 percent articaine 
anesthetic formulations is essential for achieving profound anesthesia. The 
authors found that the A200 formulation provided a level of pulpal anesthesia 
comparable with that of the A100 formulation.  
 Paul A. Moore et al (2006) 
42
., conducted a double blinded, 
randomized, multi centric clinical trials to determine the efficacy and clinical 
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anesthetic characteristics of 4%  articaine with 1:2,00,000 (A200)  epinephrine 
as compared to 4% articaine 1:1,00,000 (A100) epinephrine and 4% articaine 
without epinephrine. They concluded that inclusion of epinephrine in 4% 
articaine anesthetic formulations is essential for achieving profound 
anesthesia. They found that A200 provided a level of pulpal anesthesia 
comparable with that of A100 formulation. 
 Carlos. F. Santos et al (2007)
 5
., compared the use of 4% articaine in 
association with 1:1,00,000 epinephrine (10 ug/ml ;A100) and 1:2,00,000 
epinephrine (5 ug/ml ; A200) in lower third molar removal. They concluded 
that an epinephrine concentration of 1:1, 00,000 or 1:2, 00,000 in 4% articaine 
solution does not affect the clinical efficacy of the local anesthetic. It is 
possible to successfully use the 4% articaine formulation with a lower 
concentration of epinephrine (1: 2, 00,000or 5 ug/ml) for lower third molar 
extraction with or without bone removal. 
 Alejandro Sierra Rebollado et al (2007) 
13
., Comparative study is 
made of the anesthetic efficacy of 4% articaine versus 2% lidocaine, both with 
epinephrine 1:100,000, in truncal block of the inferior alveolar nerve during 
the surgical extraction of impacted lower third molars. A randomized double-
blind clinical trial was conducted of 30 patients programmed for the bilateral 
surgical extraction of symmetrical lower third molars in the context of the 
Master of Oral Surgery and Implantology (University of Barcelona, 
Barcelona, Spain). Following the obtainment of informed consent, two 
operators performed surgery on an extemporaneous basis, using as local 
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anesthetic 4% articaine or 2% lidocaine with the same concentration of 
vasoconstrictor (epinephrine 1:100,000). The study variables for each 
anesthetic were: latency (time to action) and duration of anesthetic effect, the 
amount of anesthetic solution used, and the need of re-anesthetize the surgical 
zone. A visual analog scale was used to assess pain during surgery, and thus 
subjectively evaluate the anesthetic efficacy of the two solutions. The results 
showed thtat statistically significant differences (p = 0.003) were observed in 
the mean duration of anesthetic effect (220.86 min. for 4% articaine vs. 168.20 
min. for 2% lidocaine). Latency, the amount of anesthetic solution and the 
need to re-anesthetize the surgical field showed clinical differences in favor of 
articaine, though statistical significance was not reached. The pain scores 
indicated similar anesthetic efficacy with both solutions. They concluded that 
4% articaine offers better clinical performance than 2% lidocaine, par-ticularly 
in terms of latency and duration of the anesthetic effect. However, no 
statistically significant differences in anesthetic efficacy were recorded 
between the two solutions. 
 Douglas Roubertson et al (2007)
13
.,  The authors conducted a 
prospective, randomized, double-blind, crossover study comparing the degree 
of pulpal anesthesia achieved by means of mandibular first molar buccal 
infiltrations of two anesthetic solutions: 4 percent articaine with 1:100,000 
epinephrine and 2 percent lidocaine with 1:100,000 epinephrine. Each of 60 
blinded adult subjects randomly received two buccal infiltrations at the first 
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molar site: one cartridge of 4 percent articaine with 1:100,000 epinephrine at 
one appointment and one cartridge of 2 percent lidocaine with 1:100,000 
epinephrine at another appointment. The injections were administered during 
two separate appointments spaced at least one week apart. The authors used an 
electric pulp tester to assess the first and second molars and the first and 
second premolars for pulpal anesthesia in three-minute cycles for 60 minutes. 
They considered anesthesia to be successful when they obtained two 
consecutive pulp test readings of 80 (meaning the subject evidenced no 
response at the maximum output on the pulp tester). The results showed that 
with the lidocaine formulation, successful pulpal anesthesia ranged from 45 to 
67 percent. With the articaine formulation, successful pulpal anesthesia ranged 
from 75 to 92 percent. There was a significant difference (P < .05) in 
anesthetic success between the lidocaine and articaine formulations for each of 
the four teeth. Pulpal anesthesia declined slowly over 60 minutes with both 
formulations. They concluded that for mandibular buccal infiltration of the 
first molar, 4 percent articaine with 1:100,000 epinephrine will result in a 
higher success rate than will 2 percent lidocaine with 1:100,000 epinephrine, 
but the duration of pulpal anesthesia will decline over 60 minutes with either 
formulation. 
 Rosenberg PA et al (2007) 
44
., conducted a  randomized, double-blind 
trial was conducted to compare the efficacy of 4% articaine with 1:100,000 
epinephrine and 2% lidocaine with 1:100,000 epinephrine when used as a 
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supplemental anesthetic. Forty-eight patients with irreversible pulpitis 
requiring supplemental buccal infiltration for endodontic therapy were given 
either 4% articaine with 1:100,000 epinephrine or 2% lidocaine with 
1:100,000 epinephrine in a double-blind manner. A standard VAS pain scale 
was used to evaluate the patient’s response to pain after a supplemental 
injection. The mean VAS score after supplemental anesthesia was 15.28 for 
4% articaine with 1:100,000 epinephrine and 19.70 for 2% lidocaine with 
1:00,000 epinephrine. The mean percentage change in VAS score was 70.5 
and 62.2% for articaine and lidocaine, respectively. They concluded that there 
was no statistically significant difference in the VAS pain score between 4% 
articaine with 1:00,000 epinephrine and 2% lidocaine with 1:00,000 
epinephrine as a supplemental anesthetic. 
 ll – Young Jung et al (2008) 21., compared the anesthetic efficacy of 
inferior alveolar nerve blocks (IANBs) with that of buccal infiltrations (BIs) in 
mandibular first molars. Using a crossover design, all subjects received a 
standard IANB or a BI of 1.7 mL of 4% articaine with 1:100,000 adrenaline 
(Septanest; Septodont, Saint-Maru-des-Fosses, France) on two appointments 
separated by at least 1 week. Pulpal anesthesia was determined by using an 
electric pulp tester. Electric pulp testing was repeated at 5, 8, 11, 15, 20, 25, 
and 30 minutes after the injections. Anesthesia was considered successful if 
the subject did not respond to the maximum output of the pulp tester at two or 
more consecutive time points. Fifty-four percent of the BI and 43% of the 
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IANB were successful; the difference was not significant (p = 0.34). The onset 
of pulpal anesthesia was significantly faster with BI (p = 0.03). In conclusion, 
BI with 4% articaine for mandibular first molars can be a useful alternative for 
clinicians because compared with IANB it has a faster onset and a similar 
success rate. 
 Ian P. Corbett,  Mohammad D. Kanaa et al (2008)
 20
.,  conducted a 
randomized, controlled trial of 31 healthy volunteer compared 4% articaine 
with 1:100,000 epinephrine buccal infiltration to buccal plus lingual 
infiltration of the same dose of drug in achieving pulpal anesthesia of 
mandibular first molar teeth. Data were compared with efficacy of an inferior 
alveolar nerve block using 2% lidocaine 1:80,000 epinephrine in a cohort of 
27 of the volunteers. Anesthesia was determined using electronic pulp testing. 
Buccal and buccal plus lingual infiltrations of articaine with epinephrine did 
not differ in efficacy in obtaining pulpal anesthesia for mandibular permanent 
first molars (p< 0.17). Efficacy of 4% articaine with epinephrine infiltrations 
for first molar pulp anesthesia was similar to that of an IANB using lidocaine 
with epinephrine over a 30-minute study period (96 and 80 episodes of no 
response to maximal stimulation respectively, (p< 0.097). Subjective tooth 
numbness was more common after IANB than buccal infiltration (p< 0.005). 
The discomfort of buccal infiltration with articaine was volume dependent                        
(p < 0.017) and similar to that of an IANB.  
Review of  literature 
 
33 
 
 Andrew hasse et al (2008)
 2
., The authors conducted a prospective, 
randomized, double-blind, crossover study comparing the degree of pulpal 
anesthesia achieved by means of mandibular first molar buccal infiltrations of 
two anesthetic solutions: 4 percent articaine with 1:100,000 epinephrine and 2 
percent lidocaine with 1:100,000 epinephrine after an inferior alveolar nerve 
(IAN) block with the use of 4 percent articaine with 1:100,000 epinephrine. 
Seventy-three blinded adult subjects randomly received buccal infiltrations at 
the first molar site with a cartridge of 4 percent articaine with 1:100,000 
epinephrine at one appointment and a cartridge of 2 percent lidocaine with 
1:100,000 epinephrine at another appointment after receiving a standard IAN 
block with the use of 4 percent articaine with 1:100,000 epinephrine in a 
crossover design. After the injections, the authors used an electric pulp tester 
to test the first molar for anesthesia in three-minute cycles for 60 minutes. 
They considered anesthesia to be successful when two consecutive 80 readings 
were obtained within 10 minutes of the IAN block and infiltration injection, 
and the 80 reading was sustained continuously through the 60th minute. The 
authors found that with the use of the 4 percent articaine formulation, 
successful pulpal anesthesia occurred 88 percent of the time for the first molar. 
With the 2 percent lidocaine formulation, successful pulpal anesthesia 
occurred 71 percent of the time. The results show a significant difference                
(P < .05) between the articaine and lidocaine formulations. They concluded 
that for a mandibular buccal infiltration of the first molar after a standard IAN 
block, 4 percent articaine with 1:100,000 epinephrine resulted in a higher 
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success rate (88 percent) than did 2 percent lidocaine with 1:100,000 
epinephrine (71 percent success rate).                     
 Leonardo. V.L Gregorio (2008)
 28
., compared the clinical efficacy of 
4% articaine with 0.5% bupivacaine both with 1: 2,00,000 epinephrine for 
lower third molar removal. They concluded that in comparison with 0.5% 
bupivacaine 4%articaine provided a shorter time to onset, and comparable 
homeostasis and postoperative pain control, with a shorter duration of soft 
tissue anesthesia in lower third molar removal. They also concluded fewer 
patients required supplemental intraoperative injections when operated with 
4% articaine. 
 Narasimhan Srinivasan et al (2009)
 35
., compared the anesthetic 
efficacy of 4% articaine and 2% lidocaine (both with 1:100,000 epinephrine) 
for buccal infiltration in patients experiencing irreversible pulpitis in maxillary 
posterior teeth and they concluded that The efficacy of 4% articaine was 
superior to 2% lidocaine for maxillary buccal infiltration in posterior teeth. 
 Nuzam .F.M et al (2010)
 38 
., claimed that previous studies have 
shown higher success rates when using an articaine formulation versus a 
lidocaine formulation for buccal mandibular first molar infiltrations. However, 
there is little information on articaine's effect in mandibular anterior teeth. 
Hence, the authors conducted a prospective, randomized, single-blind, 
crossover study comparing the degree of pulpal anesthesia obtained with 2 sets 
of mandibular lateral incisor infiltrations given in 2 separate appointments in 
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82 adult subjects. One set of infiltrations consisted of an initial labial 
infiltration of a cartridge of 4% articaine with 1:100,000 epinephrine plus a 
lingual infiltration of the same anesthetic and dose. The other set of 
infiltrations consisted of an initial labial infiltration of a cartridge of 4% 
articaine with 1:100,000 epinephrine plus a mock lingual infiltration. The 
authors used an electric pulp tester to test the lateral incisor for pulpal 
anesthesia in 2-minute cycles for 60 minutes after the injections. The results 
showed that  the labial plus lingual infiltration significantly improved the 
success rate (no response to 2 consecutive 80 readings with the pulp tester) to 
98% when compared with a labial infiltration of a cartridge of the same 
articaine formulation (76% success). They concluded that a combination labial 
and lingual infiltrations did not provide pulpal anesthesia for an hour. 
 Anna Guglielmo et al (2011) 
3
., conducted a prospective, randomized, 
single-blind crossover study was to evaluate the anesthetic efficacy of a 
combination palatal and buccal infiltration of the maxillary first molar. Using 
a crossover design, 40 subjects received two sets of maxillary first molar 
infiltrations at two separate appointments spaced at least 1 week apart. The 
anesthetic used in this study was 2% lidocaine with 1:100,000 epinephrine. 
One set of infiltrations consisted of a buccal infiltration of 1.8 mL of 
anesthetic and a palatal infiltration of 0.5 ml of anesthetic. The other set 
consisted of a buccal infiltration of 1.8 ml of anesthetic and a mock palatal 
infiltration. The first molar was pulp tested in 4-minute cycles for a total of 60 
minutes. Anesthetic success was defined as no subject response to two 
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consecutive 80 readings with an electric pulp tester. The success rates were 
88% for the buccal infiltration and 95% for the buccal plus palatal infiltration. 
The difference was not statistically significant. The buccal plus palatal 
infiltration significantly increased the incidence of pulpal anesthesia from 21 
minutes through 57 minutes. Although there was an increased incidence of 
pulpal anesthesia with the combination buccal plus palatal infiltration, 
anesthesia was not provided for 60 minutes. 
 J.G. Meechan , Jaber AA et al (2011)
 25
.,  compared the 
effectiveness of buccal and lingual local anaesthetic injections in the 
mandibular first molar region in obtaining pulpal anaesthesia in mandibular 
teeth. Twenty healthy volunteers received 1.8 mL of 4% articaine with                  
1:100,000 epinephrine as a buccal or lingual infiltration in the mandibular first 
molar region in a randomized double-blind cross-over design. The responses 
of the first molar, a premolar and the lateral incisor teeth were assessed using 
an electronic pulp tester over a 47-min period. Successful anaesthesia was 
defined as no response to maximum stimulus from the pulp tester on two or 
more consecutive tests. Success between techniques was analysed using the 
McNemar test and variations between teeth were compared with Chi-square. 
Their results showed that the number of no responses to maximum stimulation 
from an electronic pulp tester was significantly greater for all test teeth after 
the buccal injection compared with the lingual approach (P < 0.001). 
Successful anaesthesia was more likely following the buccal infiltration 
compared with the lingual method for molar (65% and 10%, respectively) and 
Review of  literature 
 
37 
 
premolar (90% and 15%, respectively) teeth. There was no difference in 
anaesthetic success for the lateral incisor.they concluded that  buccal 
infiltration at the first mandibular molar is more effective than lingual 
infiltration in the same region in obtaining anaesthesia of the mandibular first 
molar and premolar teeth.. 
           K.E.Yupp et al (2011)
 26 
.,conducted a study for review of literature 
for articaine in the study they discussed the followings a comprehensive 
review on articaine use in dentistry, compared other local anaesthetics in 
different settings,   outlined the use of articaine in children, discussed the 
controversy regarding neurotoxicity and highlighted the quality of the 
available evidence. They concluded that although there may be controversy 
regarding its safety and advantages in comparison to other local anaesthetics, 
there is no conclusive evidence demonstrating neurotoxicity or significantly 
superior anaesthetic properties of articaine for dental procedures. Articaine is a 
safe and effective local anaesthetic drug to use in all aspects of clinical 
dentistry for patients of all ages, with properties comparable to other common 
local anaesthetic agents.  Therefore, at this time, the decision to use articaine 
cannot be based on any convincing evidence of superiority over other LA 
drugs, rather the choice will be based on the personal preference and 
experiences of individual clinicians. 
            Matthew Martin, John Nusstein et al (2011)
 31
 ., compared 1.8 mL 
and 3.6 mL 4% articaine with 1:100,000 epinephrine in a mandibular buccal 
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infiltration of the first molar. The authors conducted a prospective, 
randomized, single-blind, crossover study comparing the degree of pulpal 
anesthesia obtained with 1.8 mL and 3.6 mL 4% articaine with 1:100,000 
epinephrine as a primary infiltration in the mandibular first molar. Eighty-six 
asymptomatic adult subjects randomly received a primary mandibular buccal 
first molar infiltration of 1.8 mL or 3.6 mL 4% articaine with 1:100,000 
epinephrine in two separate appointments. The authors used an electric pulp 
tester to test the first molar for anesthesia in 3-minute cycles for 90 minutes 
after the injections.the results showed that compared with the 1.8-mL volume 
of 4% articaine with 1:100,000 epinephrine, the 3.6-mL volume showed a 
statistically higher success rate (70% vs 50%). They concluded that the 
anesthetic efficacy of 3.6 mL 4% articaine with 1:100,000 epinephrine is 
better than 1.8 mL of the same anesthetic solution in a primary mandibular 
buccal infiltration of the first molar. However, they said that the success rate 
of 70% is not high enough to support its use as a primary injection technique 
in the mandibular first molar. 
            Mayes Mc Entire, John Nusstein et al (2011)
 32
., compared the 
anesthetic efficacy of 4% articaine  with 1:100,000 epinephrine versus 4% 
articaine with 1:200,000 epinephrine as a primary buccal Infiltration in the 
mandibular first molar and concluded that the anesthetic efficacy of 4% 
articaine. With 1:200,000 epinephrine is comparable to 4% articaine with 
1:100,000 epinephrine in a primary mandibular buccal infiltration of the first 
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molar. The two 4% articaine formulations showed no statistically significant 
difference when comparing anesthetic success, onset of anesthesia, or 
incidence of pulpal anesthesia. 
          Shahid hussain, B.H. Sripathi rao et al (2011)
45
., compared the 
efficacy of 4% articaine hydrochloride and 2% lignocaine hydrochloride in the 
extraction of maxillary premolars for orthodontic reasons. They concluded that 
articaine can be used as an alternative to lignocaine, for extraction of 
maxillary premolars for orthodontic reasons due to clinical advantage due to 
rapid onset, longer duration of action, and greater diffusing property over 
lignocaine and the elimination of the need for a painful palatal injection were 
demonstrated. 
 Suttapreyasri Srisurang et al (2011)
 48
., assessed and compare the 
efﬁcacy of single buccal and palatal inﬁltration of lidocaine, mepivacaine, or 
articaine with 1:100 000 epinephrine by maxillary anesthetic injection.  A 
double-blinded, randomized, clinical trial was conducted with 33 patients 
undergoing upper premolar extraction. The patients were randomly allocated 
into one of three groups, according to the local anesthetic agent used: 2% 
lidocaine, 2% mepivacaine, or 4% articaine, all with 1:100 000 epinephrine, 
and were blinded to the anesthetic used. The extent of anesthetization, pulpal 
anesthetization in adjacent teeth, pain on injection, and adverse effects of the 
anesthetic agents were assessed. The results showed that the extent of 
anesthetization produced by 4% articaine (42 mm) was statistically more 
signiﬁcant ( P < 0.05) than 2% lidocaine (33 mm) and 2% mepivacaine (32.5 
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mm). The successful anesthetization of adjacent teeth occurred more often in 
the articaine group than in the lidocaine and mepivacine groups, although not 
to a statistically signiﬁcant extent. The pain scores for the injections were 
comparable between the three groups. They concluded that local 
anesthetization using 4% articaine with 1:100 000 epinephrine covers a wider 
area of soft tissue and adjacent teeth than 2% lidocaine or 2% mepivacaine 
with 1:100,000 epinephrine, which is sufficient for the extraction of one or 
two teeth.                      
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LIST OF ABBREVIATION USED 
 
C max:    Maximum plasma concentration 
IVRA:     Intravenous regional anesthesia 
LA:          Local anesthetic 
PABA:     Para amino benzoic acid 
T max:    Time taken to reach maximum concentration 
VAS:       Visual analog scale  
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MATERIALS AND METHODS 
 A  total sample size of 100 patients undergoing extraction of 
mandibular posterior teeth  reporting to the Dept. of Oral and Maxillofacial 
Surgery , Ragas Dental College and Hospital, Chennai were planned for our 
study .Out of which 50 patients were given 4% Articaine with 1:100,000 
adrenaline with buccal and lingual infiltration and 50 patients were given 2% 
Lignocaine with 1:80,000 adrenaline using classic direct inferior alveolar 
nerve with lingual and buccal nerve block  reporting to the Dept. of Oral and 
Maxillofacial Surgery , Ragas Dental College and Hospital, Chennai. 
INCLUSION CRITERIA:  
1. Completely erupted mandibular first or second molar teeth either 
carious or periodontally weak teeth. 
2. Patients without allergic to local anesthetic drugs. 
3. Age group between 18- 40 years. 
EXCLUSION CRITERIA: 
1. Periapical abscess in relation to the tooth to be extracted. 
2. Space infection. 
3. Local infection in relation to the tooth to be extracted. 
4. Hypertensive patients. 
5. Diabetic patients. 
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1. Patients with thyroid disorders. 
2. Patients with liver diseases. 
3. Patients with renal diseases. 
4. Patients with bleeding and clotting disorders. 
5. Patients under antidepressants medication. 
6. Patients with bone diseases and disorders. 
7. Patients with altered physiological responses which affects pain 
perception mechanisms. 
8. Any condition which interacts with the mechanism of action of 
local anesthesia. 
MATERIALS USED IN THE STUDY:-(Fig.1-6) 
1. 1.7 ml of 4% Articaine HCL with 1:100,000 adrenaline 
cartridge. 
2. 2% Lignocaine HCL with 1:80,000 adrenaline. 
3. Disposable syringe 0.45 x 38 mm / 26 x 1 ½. (dia/ gauge x 
length in cm/ inches). 
4. Standard teeth extraction kit with mouth mirror, straight probe, 
moons probe, lower molar extraction forceps, lower molar root 
forceps. 
5. Breech – loading, metallic, cartridge –type, aspirating syringe. 
6. 27 gauge, 40 x 35mm disposable needle. 
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CLASSIC INFERIOR ALVEOLAR NERVE BLOCK USING 2% 
LIGNOCAINE  WITH 1:80,000 ADRENALINE :-(Fig.7,8) 
Landmarks: - Coronoid notch, pterygomandibular raphe, occlusal plane of 
mandibular posterior teeth. 
TECHNIQUE:- 
 The patient is positioned comfortably in dental chair, the head 
positioned such that when the mouth is open wide, body of the mandible is 
parallel to the floor. The index finger or thumb is used to palpate the external 
oblique ridge on the anterior border of ramus of the mandible and the coronoid 
notch is identified. The palpating finger is moved lingually across the retro 
molar trigone and on to the internal oblique ridge. While palpating intra oral 
mark with thumb the index finger is placed extra orally behind the ramus of 
mandible to access the anteroposterior width of the ramus of the mandible. 
 A syringe with a 1 ½ inch 26 gauge needle is then inserted parallel to 
the occlusal plane of mandibular teeth , at a level bisecting the finger , 
penetrating the pterygomandibular space. The needle is penetrated into the 
tissues until the bone is gently contacted on the internal surface of the ramus 
of the mandible. The needle is withdrawn by 1mm, aspirated and on negative 
aspiration 1 to 1.5 ml of 2% Lignocaine with 1:80,000 adrenaline solution is 
deposited slowly over 1 minute. The needle is now withdrawn slowly and 
Materials and methods 
 
45 
 
when one half of its inserted depth has been withdrawn, 0.5ml of solution 
deposited to anesthetize lingual nerve. 
Long buccal nerve block using 2% Lignocaine with 1:80,000 Adrenaline:- 
Landmarks:  mandibular  molars,  mucobuccal fold. 
 The index finger was used to pull the buccal soft tissue laterally for 
better visualization. Using the 26 gauge needle, such that the bevel of the 
needle facing the bone and syringe aligned parallel with the occlusal plane 
,buccal to the teeth ;the needle was inserted into the distobuccal soft tissue of 
the most distal tooth in the arch. Negative aspiration was confirmed and 0.3 to 
0.5ml solution is deposited usually at a depth of 1 or 2mm. 
BUCCAL AND LINGUAL INFILTRATION USING 4% ARTICAINE 
WITH  1:100,000 ADRENALINE:- (Fig.9,10,11) 
Landmarks: mucobuccal fold,  mucolingual fold. 
TECHNIQUE:-  
 Using breech loading, metallic, cartridge type aspirating syringe 4% 
Articaine with 1:100,000 adrenaline solution was infiltrated over the buccal 
and lingual sulcus region in relation to the mandibular molar tooth to be 
extracted. Aspiration was done before depositing the solution. The needle used 
was 27 gauge, 40 x 35 mm .About 1.2 ml of solution was deposited below the 
apex of the roots buccally  and 0.5ml below the lingual roots. After waiting for 
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5 minutes the patients were checked for objective and subjective symptoms of 
anesthesia. 
 Subjectively patient was asked about the numbness over the injected 
site, few patients experienced lower lip numbness after the infiltration. 
Objective symptom was assessed by checking manually by pressing with the 
sharp tip of the moon’s probe over the buccal and lingual gingival of the tooth 
to be extracted. If the patient experienced pain during the above an additional 
3-4 minutes was waited and the anesthesia rechecked. If the patient still had 
pain one more cartridge of 1.7ml 4% Articaine with 1:100,000 adrenaline was 
infiltrated. The procedure was repeated up to 3 cartridges with a maximum 
dose of 5.1ml. 
 After 3 cartridges, if the patient still experienced pain, the infiltration 
procedure was abandoned and a regular inferior alveolar nerve block using 2% 
Lignocaine with  1:80,000 adrenaline was performed and the tooth extracted. 
Evaluation of pain during the procedure:- 
 Efficacy was determined using a visual analog scale (VAS) ranging 
from 0 indicating no pain to 10 indicating the worst pain imaginable. The VAS 
was taken by a different operator to avoid influencing the patients during 
scoring. 
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CONSENT LETTER 
 
 I,                                  ,the undersigned hereby give my consent for the 
required Anesthetic and teeth extraction procedure on myself for the study of 
evaluating the mandibular buccal bone penetrating property of 4% Articaine 
with 1:1,00,000 adrenaline  concentration. A comparative study with 2% 
Lignocaine with 1:80,000 adrenaline concentration in patients undergoing 
lower  molar  removal. 
 I have been informed and explained the status of my problem, 
procedure or techniques of the study .I also accept as part of the study protocol 
thereby voluntarily, unconditionally, freely give my consent without any form 
of pressure in mentally sound and conscious state to participate in the study. 
NAME OF THE PATIENT: 
 
 
SIGNATURE OF THE PATIENT: 
 
 
Materials and methods 
 
48 
 
Patient name: 
Treatment plan:                                                               Age /Sex : 
Visual analogue scale scoring sheet      
 
                             
 
 
 
 
 
 
0       -     NO PAIN 
1 -3    -    MILD PAIN 
4 -6    -   MODERATE PAIN 
7 -9   -   SEVERE PAIN 
10      -   WORST PAIN 
 
 
Sr.No. PATIENT’S  RESPONSE 
0.  
1.  
2.  
3.  
4.  
5.  
6.  
7.  
8.  
9.  
10.  
Results 
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RESULTS 
 The study was performed over a period of 19 months. 100 patients 
participated in the study for the extraction of mandibular first and second 
molar. Out of the 100 patients, 50 patients were randomly selected for 4% 
Articaine with 1:100,000 adrenaline buccal and lingual infiltration and 50 
patients for 2% Lignocaine with 1:80,000 adrenaline for classic inferior 
alveolar nerve block. 
 In the 4% Articaine with 1:100,000 adrenaline group, 5 patients 
underwent extraction of mandibular first and second molar simultaneously, 
these 5 patients are discussed separately. Hence, the sample size is uneven. 50 
patients for 2% Lignocaine with 1:80,000 adrenaline group and 45 patients for 
4% Articaine group with a total sample size of 95 individuals. (Table.1, 
Table.2) 
Demographic data :-(Graph .1) 
 The patients selected for the present study were within the age group of 
20- 40 years. Mean age  group for 2% Lignocaine with 1:80,000 adrenaline 
was  31.4 + /- 7.9 years ,out of which 27 individuals were females and  23 
were males. Mean age group for the 4% Articaine 1:100,000 adrenaline group 
was 30.2 +/- 6.4 years, out of which 21 individuals were females and 19 were 
males.  
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Drug volume:- (Graph .2) 
 We administered as much as drug that was necessary to achieve 
adequate anesthesia in all the subjects within normal limited dosages. The 
mean drug volume was 3.3+/-1.1ml, ranging from 2.5- 5ml for 2% Lignocaine 
with 1:80,000 adrenaline group and 3.08 +/- 4.3ml, ranging from 1.8 to 5.4ml 
for 4% Articaine with 1:100,000 adrenaline group. 
Pain ratings:- (Table.3) (Graph .3) 
 The pain ratings for both the groups were analyzed using Visual 
Analogue Scale. Data was entered and analysed using SPSS (10.05). Mann – 
Whitney ‘U’ test was employed to assess the efficacy of 4% Articaine with 
1:100,000 adrenaline buccal and lingual infiltration in comparison to 2% 
Lignocaine with 1:80,000 adrenaline classic inferior alveolar nerve block.                
P < 0.05 was considered to be statistically significant. We found no statistical 
difference between the two treatment groups with respect to pain using VAS 
scoring system.   
 The mean pain score for 2% Lignocaine with 1:80,000 adrenaline 
group was 1.16 +/- 1.8 and for 4% Articaine with 1:100,000 adrenaline was 
2.0+/- 3.0 with a mode of 0 for both the groups. 
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Graph.2: MEAN DRUG VOLUME 
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Table.3: COMPARISION OF PAIN SCORES BETWEEN 2%LIGNOCAINE 
WITH 1:80,000 ADRENALINE AND 4% ARTICAINE WITH 1:1,00,000 
ADRENALINE 
 
 
Graph.3: MEAN PAIN SCORE 
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2% Lignocaine with 1:80,000 adrenaline 4% Articaine with 1:1,00,000 adrenaline
Group N Mean+/- S.D Mode P - Value 
2% Lignocaine with 
1:80,000 adrenaline 
50 1.16 +/- 1.8 0  
 
0.338 
 
4% Articiane with 
1:100,000 adrenaline 
45 2.0 +/-3. 0 0 
Total 95   
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DISCUSSION 
 Using local anesthetics to control a patient’s pain is one of the most 
important factors for successful treatment. Articaine is not exactly a new drug. 
Articiane was identified in the older, mostly German literature as articaine, 
carticaine, or HOE 40 045. Articaine is unique among available amide local 
anesthetics because it has a thiophene moiety rather than the typical benzene 
group. Articaine unlike other amide local anesthetics undergoes 
biotransformation in both liver and plasma thus cleared more quickly from the 
body 
29,38,51
.  
 Articaine has a reputation of providing an improved local anesthetic 
effect. The available literature indicates that articaine is equally effective 
when statistically compared to other local                                                        
anesthetic
 1,7,6,8,12,26,27,29,30,36,37,41,43,44,46,52
 . Here the results of a randomized 
clinical trial are discussed, 4% Articaine with 1:100,000 adrenaline being 
compared with 2% Lignocaine with 1:80,000 adrenaline for purpose of 
evaluating the efficacy of Articaine. 2% Lignocaine with 1:80,000 adrenaline 
is chosen as a reference substance, as its effects are well documented 
29
. Since 
the study used identical protocols, the result obtained were comparable, 
combined analysis of the trial was valid.  
 Articaine is manufactured as a 4% local anesthetic solution .This is in 
contrast to Lignocaine which is a 2% solution .Equal analgesic efficacy along 
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with lower systemic toxicity allows use of articaine in higher concentration 
than other amide type local anesthesia 
39
. 
 This is advantageous with respect to the required bone penetration and 
hence it is possible to inject smaller volumes thereby minimizing the injection 
induced pain. 
 4% Articaine is combined with either 1:100,000 adrenaline or 1: 
200,000 adrenaline. Numerous studies have evaluated anesthetic activity of 
articaine in these 2 distinct concentrations of epinephrine 
5,17,32,47 
.In one such 
study conducted by Elliot V. Hersh 
5
 various haemodynamic parameters were 
evaluated between 4% articaine with 1:100,000 and 1:200,000 adrenaline such 
as systolic pressure, diastolic pressure, mean pressure, oxygen saturation and 
found that the pharmacokinetic profile between A100 and A200 were similar. 
However they cautioned the use of A100 in patients with cardiovascular 
diseases. 
 In our study the inclusion criteria was specific not to include such 
patients hence, we continued the use of 4% Articaine with 1:100,000 
adrenaline. 
 Various studies have compared anesthetic efficacy of 2% Lignocaine 
with 1:80,000 adrenaline versus 4% Articaine with 1:100,000 adrenaline 
given as a supplementary buccal infiltration after a classical inferior alveolar 
nerve block technique in cases of inadequate lower mandibular molar 
anesthesia for various dental procedures and concluded that 4% Articaine with 
1:100,000 adrenaline infiltration was higher or similar in efficiency to 
Discussion 
 
53 
 
lignocaine 
2,13,32,44 
. Il – Young Jung et al 21 indirectly compared the anesthetic 
efficacy of 4% articaine with 1:100,000 adrenaline buccal infiltration to 2% 
Lignocaine with 1:80,000 adrenaline Inferior alveolar nerve block. He 
concluded that 4% articaine with 1:100,000 adrenaline buccal infiltration for 
mandibular first molar can be used as an alternative for 2% Lignocaine 
1:80,000 adrenaline Inferior alveolar nerve block as Articaine infiltration has 
faster onset and similar success rate. However he suggested that further 
studies are needed to compare the effectiveness of both the methods directly. 
 The advantages of 4% Articaine with 1:100,000 adrenaline infiltration 
over 2% Lignocaine with 1:80,000 adrenaline classical Inferior alveolar nerve 
block are that 4% Articaine infiltration is a simpler technique than classic 2% 
Lignocaine Inferior alveolar nerve block, articaine infiltration anesthetizes 
less soft tissue 
24
, has shorter duration of anesthesia as it is metabolized both 
in the liver and plasma
26,29,39
,avoids trismus and non- surgical paresthesia as a 
result of damage from the needle to inferior alveolar and lingual nerves
 18,19,26
. 
It reduces concentration related neurotoxicity
18,19
. Articaine infiltration can be 
advantageous in hemophilic patients in order to reduce the chances of 
dangerous hemorrhage 
24
.
 
 The results of the present study shows infiltration anesthesia efficacy 
in the mandibular molar region with 4% Articaine with 1:100,000 adrenaline 
in adults of approximately 51.1%. Therefore the study provides evidence to 
support the view that mandibular buccal and lingual infiltration with 4% 
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Articaine with 1:100,000 adrenaline can be as effective as an classic Inferior 
alveolar nerve block with 2% Lignocaine with 1:80,000 adrenaline in adult 
patients undergoing erupted mandibular first and second molar teeth 
extraction. 
 Buccal infiltration with 4% Articaine with 1:100,000 adrenaline has 
been shown to achieve higher success rates in mandibular molar anesthesia 
than that reported with a buccal infiltration of 2% Lignocaine with 1:100,000 
adrenaline. This increase in efficacy may be as a result of a concentration 
effect or greater diffusion of articaine because of the thiophene ring which 
helps the anesthetic agent to readily diffuse through the buccal bone 
20
. 
 Factors influencing the latency of anesthesia are intrinsic properties of 
the drug, anesthetic technique and it is directly influenced by the 
corresponding pKa value - smaller pKa values being associated to a shorter 
latency. The pKa of 4% articaine solution being 7.8 
1
 . 
 In our study of 100 patients there were no adverse effects or 
complications observed  although there are few study reports showing 
increased incidence of nerve alterations , paresthesia and hyperesthesia with 
4% Articaine Inferior alveolar nerve block 
18,19
, we did not encounter any 
adverse effects during or after the procedure with the 4% Articaine 
infiltration. Keeping the efficacy in mind, articaine is a safer local anesthetic 
agent similar to other group if local anesthetics 
26
. 
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 In this study, out of the total 100 patients 50 patients were randomly 
selected for 2% Lignocaine with 1:80,000 classic inferior alveolar nerve block 
and 50 patients for 4% Articaine with 1:100,000 adrenaline buccal and lingual 
infiltration undergoing lower mandibular first or second molar extraction. Out 
of the 50 patients in the articaine group 5 patients underwent extraction of 
both the mandibular first and second molar teeth. Hence they are discussed 
separately to avoid bias. Out of the 5 patients 2 patients underwent extraction 
of 46, 47 and 3 patients underwent extraction of 36, 37. Two patients out of 
the total 5 needed the use of additional 2.5ml of 2% lignocaine block after the 
use of 3 cartridges (5.4 ml) of 4% articaine. The VAS pain score being 10& 4 
with the use 4% Articaine in these patients. The remaining 3 patients received 
5.4 ml, 1.8ml, 3.6 ml of articaine with VAS pain score of 2, 1, 0 respectively. 
 In the present study we found VAS scores between 0 to 10 and no 
significant difference in pain experience with 4% articaine or 2% lignocaine.  
In the articaine group 51.1% of patient reported no pain, 26.6% mild pain , 
4.4% moderate pain, 13.3% sever pain and 4.4% worst pain. In the lignocaine 
group 58% of patients reported no pain, 30% mild pain, 8% moderate pain, 
4% sever pain. The average pain score for 4% articaine group was 2.0 + /- 3.0 
and for lignocaine group was 1.16 +/- 1.8. The pain scores between both the 
groups were analyzed using Mann – Whitney ‘U’ test with a P Value of 0.338 
obtained. Hence no significant difference in pain score was established 
between both the groups. 
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 Pain measurement is difficult to establish, because its perception and 
intensity are multifactorial, encompassing sensorial and affective factors. 
Multiple variable factors exist like technique variability, anatomic variations, 
complexity of procedure and reporting error. Pain itself is multifactorial; 
perception and pain reaction varies greatly among individuals Although VAS 
may show deficiencies regarding understanding and perception, it provides a 
validated and meaningful measure of anesthetic efficiency, being used for this 
purpose by many authors
.
 
 To the best of our knowledge, no study has compared the efficacy of 
4% Articaine with 1:100,000 adrenaline buccal and lingual local infiltration 
versus 2% Lignocaine with 1:80,000 adrenaline Inferior alveolar nerve block 
for the extraction of erupted mandibular first and second molar in adults. 
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SUMMARY AND CONCLUSION 
 A classic inferior alveolar nerve block technique is technique sensitive 
with high failure rates 
24
 and complications when compared to a buccal and 
lingual infiltration (field block technique)
 18,19
. Due to the thick cortical buccal 
plate 2% Lignocaine 1:80,000 adrenaline cannot penetrate the bone and 
anesthetize the adult mandibular molar teeth. Hence for a single mandibular 
molar tooth extraction Inferior alveolar nerve block is inevitable .But 4% 
Articaine 1:100,000 adrenaline has been advantageous for the surgeon which 
anesthetizes the mandibular  molar tooth adequately only by buccal and 
lingual infiltration and allows to complete the tooth extraction procedure  
successfuly thereby avoiding many complications of  Inferior alveolar nerve 
block. This study recommends the use of 4% Articaine with 1:100,000 
adrenaline to be given as buccal and lingual infiltration in adult patients 
undergoing erupted mandibular molar teeth extraction. However, further 
studies are needed to estimate the onset, duration of anesthesia and their use in 
cases of irreversible pulpitis in case of erupted mandibular teeth extraction in 
adults. 
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 Fig.1: 4% ARTICAINE WITH 1:100,000ADRENALINE CARTRIDGE 
PACKAGE 
 
 
Fig.2: 4 % ARTICAINE WITH 1:1,00,000 ADRENALINE CARTRIDGE 
 
 
 
 Fig.3: BREECH LOADED METALLIC ASPIRATING TYPE SYRINGE , 
4% ARTICAINE WITH 1:1,00,000 ADRENALANE CARTRIDGE , 
DISPOSABLE  NEEDLE 
 
 
Fig.4: EXTRACTION KIT WITH 4% ARTICAINE WITH  1:1,00,000 
ADRENALINE 
 
 Fig.5: 2% LIGNOCAINE WITH 1:80,000 ADRENALINE BOTTLE 
 
 
 
Fig.6: 1 ½ INCH 26 GAUGE NEEDLE AND PLASTIC SYRINGE 
 
 
 
 Fig.7: CLASSIC INFERIOR ALVEOLAR AND LINGUAL NERVE 
BLOCK TECHNIQUE USING 2% LIGNOCAINE WITH 1:80,000 
ADRENALINE 
 
 
Fig.8: BUCCAL NERVE BLOCK USING 2% LIGNOCAINE WITH 
1:80,000 ADRENALINE 
 Fig.9:MANDIBULAR MOLAR TOOTH WITH PERIODONTITIS 
 
Fig.10: BUCCAL INFILTRATION 
 Fig.11: LINGUAL INFILTRATION 
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Table.1: 2 %LIGNOCAINE WITH 1:80,000 ADRENALINE INFERIOR ALVEOLAR NERVE 
BLOCK 
Patient no Age  Sex 
 
Tooth 
extracted  
Kind of pathology Amount 
of 
lignocaine 
used 
Pain 
score 
1 36 yrs F 36 CARIES 2.5ml 0 
2 30 yrs M 36 CARIES 2.5 ml 0 
3 40 yrs M 46 PERIODONTITIS 2.5 ml 0 
4 20 yrs M 46 CARIES 2.5 ml  0 
5 28 yrs F 46 CARIES 5 ml 1 
6 24 yrs F 36 CARIES 2.5 ml 1 
7 39 yrs M 47 CARIES 5 ml 7 
8 24 yrs M 36 CARIES 2.5 ml 0 
9 30 yrs F 37 CARIES 2.5 ml 0 
10 25 yrs F 47 CARIES 5 ml 0 
11 35 yrs F 36 CARIES 2.5 ml 0 
12 36 yrs M 37 CARIES 5 ml 2 
13 27 yrs F 46 CARIES 2.5 ml 1 
14 20 yrs F 36 CARIES 5 ml 1 
15 33 yrs F 46 CARIES 2.5 ml 0 
16 32 yrs M 46 CARIES 2.5 ml 0 
17 35 yrs F 37 CARIES 5 ml 0 
18 25 yrs F 37 CARIES 2.5 ml  0 
19 30 yrs M 47 CARIES 2.5 ml 0 
20 38 yrs M 37 CARIES 5 ml 0 
21 24 yrs F 47 CARIES 2.5 ml 7 
22 24 yrs F 46 CARIES 5 ml 2 
23 20 yrs F 47 CARIES 2.5 ml 3 
24 36 yrs F 46 CARIES 2.5 ml 0 
25 40 yrs M 36 CARIES 2.5 ml 2 
26 26 yrs F 46 CARIES 5 ml 1 
27 26 yrs M 36 CARIES 2.5 ml 2 
28 30 yrs F 36 CARIES 2.5 ml 0 
29 32 yrs M 37 CARIES 5 ml 0 
30 30 yrs M 46 CARIES 2.5 ml 0 
31 20 yrs M 36 CARIES 2.5 ml 1 
32 21 yrs F 37 CARIES 2.5 ml 1 
33 39 yrs M 46 CARIES 2.5 ml 0 
34 40 yrs  F 36 CARIES 5 ml 3 
35 31 yrs M 47 CARIES 5 ml 3 
36 37 yrs F 36 CARIES 5 ml 5 
37 37 yrs F 36 CARIES 2.5 ml 0 
38 40 yrs F 36 CARIES 2.5 ml 1 
39 24 yrs M 37 CARIES 2.5 ml 0 
40 27 yrs M 47 CARIES 2.5 ml 0 
41 36 yrs M 46 CARIES 2.5 ml 0 
42 40 yrs M 37 CARIES 5 ml 0 
43 32 yrs M 37 CARIES 2.5 ml 0 
44 33 yrs F 36 CARIES 5 ml 4 
45 39 yrs F 46 CARIES 5 ml 5 
46 39 yrs M 47 CARIES 2.5 ml 0 
47 40 yrs F 37 CARIES 2.5 ml 0 
48 38 yrs M 37 CARIES 2.5 ml 5 
49 32 yrs F 46 CARIES 2.5 ml 0 
50 34 yrs F 47 PERIODONTITIS 2.5 ml 0 
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Table.2: 4% ARTICAINE WITH 1:1,00,000 ADRENALINE BUCCAI AND LINGUAL 
INFILTRATION 
Patient no Age Sex Tooth 
Extracte
d 
Kind of pathology Amount 
of 
Articaine 
used 
Pain 
score 
Lignocaine Pain score 
after 
use of 
lignocaine 
1 20yrs F 36 CARIES 1.8 ml 0   
2 40yrs M 37 PERIODOTITIS 1.8 ml 0   
3 29yrs M 46 CARIES 5.4 ml 4 + 0 
4 20yrs M 36 CARIES 3.6 ml 0   
5 36yrs F 46,47 CARIES  5.4 ml 10 + 0 
6 20yrs F 46 CARIES 3.6 ml 1 + 0(2B) 
7 30yrs F 47 CARIES 5.4 ml   7   
8 32yrs F 37 CARIES 3.6 ml 0   
9 32yrs F 36,37 CARIES 5.4 ml 4 + 0 
10 21 yrs   F 37 CARIES 1.8 ml   0   
11 40 yrs   M 37 CARIES AND 
PERIODONTITIS 
3.6 ml 0   
12 25 yrs   M 36 CARIES 5.4 ml 7 + 7 
13 22yrs M 36,37 CARIES 5.4 ml 2   
14 38 yrs   M 47 PERIODONTITIS 3.6 ml 0   
15 26 yrs   F 46 CARIES 1.8 ml 0   
16 34 yrs   F 46 CARIES 1.8 ml   0   
17 20 yrs   F 36 CARIES 1.8 ml   0   
18 25 yrs   M 36 TOOTH 
FRACTURE 
3.6 ml   8   
19 20 yrs   F 46 CARIES 3.6 ml 7 + 0 
20 40 yrs   F 36 CARIES 1.8 ml     0   
21 35 yrs   M 46 CARIES 1.8 ml 0   
22 38 yrs   F 37 RCT AND 
FRACTURED 
3.6 ml   3 + 0 
23 23 yrs M 36 CARIES 3.6 ml 0   
24 21yrs F 46 CARIES 1.8 ml   1   
25 32 yrs   M 36 CARIES 1.8 ml 1   
26 21 yrs   M 36 CARIES 3.6 ml 10   
27 40 yrs   M 46 PERIODONTITIS 1.8 ml 0   
28 39  yrs M 37 PERIODONTITIS 1.8 ml 0   
29 34 yrs   M 36 CARIES 3.6 ml   1   
30 38 yrs   M 46 CARIES 3.6 ml 0   
31 38 yrs   F 47 PERIODONTITIS 1.8 ml 0   
32 40 yrs F 37 CARIES 1.8 ml 1   
33 30yrs M 46,47 CARIES 1.8 ml 1   
34 20  yrs M 36 CARIES 3.6 ml   0   
35 40 yrs M 47 PERIODONTITIS 5.4 ml 0   
36 36 yrs   M 46 PERIODONTITIS 3.6 ml 0   
37 20 yrs   M 36 CARIES 1.8 ml   1   
38 20 yrs   F 46 CARIES 3.6 ml 7 + 0 
39 35 yrs   M 36 CARIES 5.4 ml   3 + 0 
40 40 yrs  M 36,37 CARIES 3.6 ml 0   
41 26 yrs   M 36 CARIES 1.8 ml   1   
42 25 yrs   M 37 CARIES 3.6 ml 7   
43 39 yrs   M 37 CARIES 3.6 ml   2   
44 36  yrs F 47 CARIES 1.8 ml 0   
45 25  yrs F 36 CARIES 1.8 ml 0   
46 35  yrs M 36 CARIES 5.4 ml 10 + 0 
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2B – 2 nerve blocks 
 
 
 
 
 
 
47 20  yrs F 36 CARIES 3.6 ml   6 + 0 
48 24 yrs   M 46 CARIES 5.4 ml   1   
49 40 yrs M 47 PERIODONTITIS 1.8 ml   0   
50 40  yrs M 37 PERIODONTITIS 1.8 ml 1   
